Archives

The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI

For Immediate Release Chicago, IL – November 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eli Lilly LLY, iShares MSCI Philippines ETF EPHE, […]

Assessment of thyroid cancer risk associated with glucagon‐like peptide 1 receptor agonist use

Abstract Aims Published literature has raised concerns regarding a causal association between glucagon-like peptide 1 receptor agonist (GLP-1RA) use and thyroid cancer risk in adults. In this analysis, we evaluated the association between thyroid cancer risk and GLP-1RA use. Materials and Methods Our evaluation included data from (i) 93 liraglutide or semaglutide phase 2 and […]

Michelle Obama sparks Ozempic weight loss rumors with new photoshoot

Former US first lady, Michelle Obama has sparked Ozempic weight loss rumors after she showed off a seemingly slimmer figure in a new photoshoot. Obama, 61, posed in the new shoot by famed photographer Annie Leibovitz, sharing behind-the-scenes footage on her social media.Before now, the author and podcast host’s fashion choices have been lauded by many, with […]

Novo Nordisk Shares Dropped 12% as Semaglutide Fails Alzheimer’s Trial

Novo Nordisk shares dropped 12% after the company announced that semaglutide, the GLP-1 drug behind Ozempic and Wegovy, failed to show any benefit in slowing cognitive decline in early Alzheimer’s disease. The phase 3 EVOKE and EVOKE-Plus trials found no meaningful difference between semaglutide and placebo on key cognitive and functional measures, prompting Novo Nordisk […]

Michelle Obama’s slimmer look sparks online rumors. Here’s why

Michelle Obama shared photos from a shoot with Annie Leibovitz, sparking baseless speculation about weight-loss medication. While some online users theorized about her appearance, Obama has previously discussed natural changes from menopause and a mindful approach to health. The article also touches on the use and side effects of GLP-1 medications like Ozempic.

Zepbound & Tan France Campaign For “Changing The Thread” Around Obesity

In recent years, we’ve seen the conversation around obesity slowly change. For all of modern history, obesity has been treated like a lifestyle decision, the result of poor choices from weak people. But, as science has moved on, we’ve learned that there’s a lot more to it than that. Genetics play a tremendous role in […]

$NVO Faces Market Pressure Follow by Alzheime Clinical Trial

$NVO Faces Market Pressure Follow by Alzheime Clinical Trial Novo Nordisk A/S Sponsored ADR Class B BATS:NVO KalaGhazi Shares of Novo Nordisk (NYSE: NVO) found themselves among the session’s most significant decliners on Monday, pressured by discouraging news from the pharmaceutical giant’s pipeline. The company announced that its highly anticipated clinical trial, which investigated the […]

Weight-loss drug no silver bullet for Alzheimer’s as big trial fails

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer’s disease (AD), as two-year clinical trials end in disappointment for patients, medical scientists and drugmaker Novo Nordisk. Continue Reading Category: Alzheimer’s & Dementia, Brain Health, Body and Mind Tags: Novo Nordisk, Alzheimer’s disease, Semaglutide, Ozempic, clinical trials, Inflammation, Brain, GLP-1 […]

GLP-1 discontinuation associated with more weight gain and pregnancy complications

In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and have higher risks of diabetes and hypertensive disorders during pregnancy, and experienced preterm delivery more so than people who had never taken GLP-1 […]